626 related articles for article (PubMed ID: 34224725)
1. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
[TBL] [Abstract][Full Text] [Related]
2. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
[TBL] [Abstract][Full Text] [Related]
3. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
[TBL] [Abstract][Full Text] [Related]
4. Guan Xin Dan Shen formulation protects
Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388
[TBL] [Abstract][Full Text] [Related]
5. Salidroside protects against cardiomyocyte apoptosis and ventricular remodeling by AKT/HO-1 signaling pathways in a diabetic cardiomyopathy mouse model.
Ni J; Li Y; Xu Y; Guo R
Phytomedicine; 2021 Feb; 82():153406. PubMed ID: 33422954
[TBL] [Abstract][Full Text] [Related]
6. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
[TBL] [Abstract][Full Text] [Related]
7. Irisin ameliorates high glucose-induced cardiomyocytes injury via AMPK/mTOR signal pathway.
Deng J; Zhang N; Chen F; Yang C; Ning H; Xiao C; Sun K; Liu Y; Yang M; Hu T; Zhang Z; Jiang W
Cell Biol Int; 2020 Nov; 44(11):2315-2325. PubMed ID: 32770767
[TBL] [Abstract][Full Text] [Related]
8. FNDC5/Irisin inhibits pathological cardiac hypertrophy.
Yu Q; Kou W; Xu X; Zhou S; Luan P; Xu X; Li H; Zhuang J; Wang J; Zhao Y; Xu Y; Peng W
Clin Sci (Lond); 2019 Mar; 133(5):611-627. PubMed ID: 30782608
[TBL] [Abstract][Full Text] [Related]
9. Zonisamide, an antiepileptic drug, alleviates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress.
Tian JH; Wu Q; He YX; Shen QY; Rekep M; Zhang GP; Luo JD; Xue Q; Liu YH
Acta Pharmacol Sin; 2021 Mar; 42(3):393-403. PubMed ID: 32647341
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model.
Wu B; Huang XY; Li L; Fan XH; Li PC; Huang CQ; Xiao J; Gui R; Wang S
J Cell Mol Med; 2019 Nov; 23(11):7651-7663. PubMed ID: 31565849
[TBL] [Abstract][Full Text] [Related]
12. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
13. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.
Korkmaz-Icöz S; Al Said S; Radovits T; Li S; Brune M; Hegedűs P; Atmanli A; Ruppert M; Brlecic P; Lehmann LH; Lahrmann B; Grabe N; Yoshikawa Y; Yasui H; Most P; Karck M; Szabó G
Cardiovasc Diabetol; 2016 May; 15():75. PubMed ID: 27153943
[TBL] [Abstract][Full Text] [Related]
14. FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress.
Geng Z; Fan WY; Zhou B; Ye C; Tong Y; Zhou YB; Xiong XQ
J Transl Med; 2019 Apr; 17(1):107. PubMed ID: 30940158
[TBL] [Abstract][Full Text] [Related]
15. Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses.
Zhu D; Wang H; Zhang J; Zhang X; Xin C; Zhang F; Lee Y; Zhang L; Lian K; Yan W; Ma X; Liu Y; Tao L
J Mol Cell Cardiol; 2015 Oct; 87():138-47. PubMed ID: 26225842
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis.
Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D
J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607
[TBL] [Abstract][Full Text] [Related]
17. Luteolin Attenuates Diabetic Myocardial Hypertrophy by Inhibiting Proteasome Activity.
Li XB; Rekep M; Tian JH; Wu Q; Chen M; Yang S; Zhang LX; Zhang GP; Qin Y; Yu XY; Xue Q; Liu YH
Pharmacology; 2023; 108(1):47-60. PubMed ID: 36423586
[TBL] [Abstract][Full Text] [Related]
18. Influence of trimetazidine on myocardial injury in mice with diabetic cardiomyopathy.
Zhao D; Ma J; Sun Y; Huang W; Fan J; Ye M; Hu B; Sun X
J Diabetes Complications; 2024 May; 38(5):108744. PubMed ID: 38613990
[TBL] [Abstract][Full Text] [Related]
19. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
20. Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways.
Ren BC; Zhang YF; Liu SS; Cheng XJ; Yang X; Cui XG; Zhao XR; Zhao H; Hao MF; Li MD; Tie YY; Qu L; Li XY
J Cell Mol Med; 2020 Nov; 24(21):12355-12367. PubMed ID: 32961025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
